[The effects of combined hepatectomy and immuno-chemotherapy on postoperative recurrence rate of primary liver cancer].
121 cases with primary liver cancer were divided into four groups: OP: resection only (30 cases); OC: combined operative resection and chemotherapy (27 cases); OI: combined operative resection and immunotherapy (31 cases); OI: combined operative resection and immuno-chemotherapy (33 cases). The results showed that one year recurrence rate was 56.7%, 40.7%, 32.3% and 27.3%, respectively. The recurrence rate of group OI and group OIC were significantly lower than that of group OP and group OC. It indicated that combined operation and immuno-chemotherapy is useful in preventing post operative recurrence.
Zhou
W
W
East Institute of Hepatobiliary Surgery, Changhai Hospital, Second Military Army Medical University.
Wu
M
M
Chen
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006498:Hepatectomy; D006801:Humans; D016219:Immunotherapy, Adoptive; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D008113:Liver Neoplasms / Q000601:surgery / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000517:prevention & control